SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000929638-23-002058
Filing Date
2023-07-24
Accepted
2023-07-24 16:01:15
Documents
1
Period of Report
2023-07-20

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 8014
  Complete submission text file 0000929638-23-002058.txt   11328
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Reporting) CIK: 0001583977 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39894 | Film No.: 231105034

Mailing Address C/O CORMORANT ASSET MANAGEMENT, LP 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address
Chen Bihua (Reporting) CIK: 0001599214 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39894 | Film No.: 231105031

Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 617-848-3429
Cormorant Global Healthcare Master Fund, LP (Reporting) CIK: 0001618442 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39894 | Film No.: 231105033

Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0370
Cormorant Private Healthcare Fund II, LP (Reporting) CIK: 0001747677 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39894 | Film No.: 231105032

Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 (617) 616-8188
GreenLight Biosciences Holdings, PBC (Issuer) CIK: 0001822691 (see all company filings)

IRS No.: 851914700 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences